Global Spirometer Market Size Insights Forecasts to 2032

• The Global Spirometer Market Size was valued at USD 1.1 Billion in 2022.
• The Market Size is Growing at a CAGR of 11.2% from 2022 to 2032.
• The Worldwide Spirometer Market Size is expected to reach USD 3.2 Billion by 2032.
• Asia Pacific is expected to grow the significnat during the forecast period.

The Global Spirometer Market Size is expected to reach USD 3.2 Billion by 2032, at a CAGR of 11.2% during the forecast period 2022 to 2032.    

Spirometry is a standard test that measures how much air an individual inhales and exhales to determine how well their lungs perform. It aids in the diagnosis of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory diseases. The test uses a spirometer to evaluate lung conditions and determine whether or not a treatment for a chronic lung condition is effective. Furthermore, asthma is the most frequent cause of respiratory illness, affecting more than 14% of children worldwide and rising. Furthermore, public and commercial groups are working together to create equipment for controlling and diagnosing respiratory disorders including COPD and asthma. Furthermore, industry participants are aggressively investing in the introduction of technologically advanced gadgets and software to grow the spirometer market growth. Manufacturers are developing spirometers with enhanced designs and features to ease the difficult procedure of pulmonary function testing for patients and medical professionals. The primary goal is to create spirometers with increased and improved patient comfort that are free of problems. In addition, companies are implementing novel packing processes to prevent bacterial contamination. Such technological advancements make diagnostic procedures easier and more straightforward for patients.

Driving Factors

Respiratory disorders are among the world's major causes of death, accounting for five of the top thirty. The third leading cause of death is chronic obstructive pulmonary disease (COPD). Early detection and diagnosis can help in the treatment of certain disorders. Spirometry is an important device in this regard because it helps to understand the severity of the infection and avoids misdiagnosis. As the prevalence of such respiratory disorders rises, the spirometers market is expected to grow during the forecast period. Age affects the effectiveness of important organs and functions in the body. Lung function tests are required to assess the basic function of the lungs. PFTs, which comprise lung volumes, lung capacities, rates of flow, and gas exchange, provide physicians with information that aids in the diagnosis of many lung illnesses, particularly COPD. The main market participants' large investments in extended research and development of novel and sophisticated diagnostic and monitoring technologies are projected to enable early diagnosis of COPD. As a result, technological advancements are projected to have a significant impact on the spirometer market.

Restraining Factors       

Despite the global prevalence of asthma and COPD, certain factors limit the use of these devices. Among these, a lack of skilled workforce for conducting diagnostic tests is expected to limit market growth. Pulmonary function testing is a series of breathing tests that can be led by trained pulmonary function technologists. However, skilled healthcare professionals are in short supply in developing countries. The primary cause of this shortage is the immigration of healthcare workers to developed countries. The desire to migrate to higher-income countries is mainly driven by the desire for better wages and working conditions.

Market Segmentation

By Product Type Insights

The device segment is expected to hold the largest share of the global spirometer market during the forecast period.

Based on the product type, the global spirometer market is classified into devices, software, accessories & consumables. Among these, the device segment is expected to hold the largest share of the spirometer market during the forecast period. The global market is experiencing substantial technological improvements with the goal of improving testing capabilities, which has resulted in an increase in demand for advanced equipment. Furthermore, start-ups and important players began investing in the industry to create devices for effective management of respiratory disorders, resulting in device domination.

By Type Insights

The peak flow meters segment is witnessing significant CAGR growth over the forecast period.

Based on the type, the spirometer market is segmented into volume measurement and peak flow meters. Among these, the peak flow meters segment is dominating the market with the largest revenue share over the forecast period. The device's dominance can be attributed to its ability to produce accurate results while remaining easy to use. Due to the rising use of the devices in asthma, cystic fibrosis, and other diseases, the volume measurement sector is expected to grow at a faster CAGR than peak flow meters over the forecast period. Furthermore, the widespread use of spirometry devices for volume assessments has resulted in increasing product sales.

By Application Insights

The chronic obstructive pulmonary disorder (COPD) segment is witnessing significant CAGR growth over the forecast period.

Based on application, the global spirometer market is segmented into chronic obstructive pulmonary disorder (COPD), asthma, and others. Among these, the chronic obstructive pulmonary disorder (COPD) segment is witnessing significant CAGR growth over the forecast period owing to the increasing incidence of pulmonary infection among patients. These gadgets are currently being tested in laboratories to see if they may be used to treat cystic fibrosis and other respiratory illnesses. During the projection period, this factor is expected to contribute to the expansion of the others section.

By End-User Insights

The hospitals segment is witnessing significant CAGR growth over the forecast period.

Based on end-users, the global spirometer market is segmented into hospitals, diagnostic centers, homecare settings, physician/primary care offices or clinics, and other facilities. Among these, the hospitals segment is witnessing significant CAGR growth over the forecast period. The dominance can be attributed to rising healthcare costs, which have resulted in the development of improved pulmonary function testing instruments. The rapidly growing aging population, increased reimbursements for clinical tests performed in hospitals, and the introduction of sophisticated spirometer devices are the factors driving the market growth during the forecast period.

Regional Insights

North America dominates the market with the largest market share over the forecast period.

North America is dominating the market share over the forecast period, owing to the growing prevalence of chronic respiratory disorders in the region, as well as the increasing acceptance of technologically advanced equipment, can be linked to the region's significant share of this market segment. This region's domination can be attributed to the rising prevalence of COPD, asthma, and other respiratory illnesses. This has increased the financial strain on the healthcare system, prompting the creation of precision equipment to address the problem. The condition is putting a significant strain on healthcare. The disease widespread frequency is expected to increase demand for diagnostic devices. The presence of key players in the region has led to North America's dominance. This, together with sufficient regulatory policies in the United States and Canada, is responsible for the region's dominance in the global market.

The Asia Pacific market is expected to grow at a significant CAGR growth rate during the forecast period, owing to the increasing number of firms entering the unexplored Asian economies. Furthermore, market participants in this region are making significant expenditures, which is projected to drive the spirometer market growth.

List of Key Market Players

• Medical International Research (MIR)
• Morgan Scientific
• COSMED srl
• Ganshorn Medizin Electronic GmbH
• ndd Medizintechnik AG
• VYAIRE
• MGC Diagnostics Corporation
• nSpire Health Inc.
• Welch Allyn
• Sibelmed
• Schiller
• SDI Diagnostics
• Smiths Medical

Key Market Developments

• In August 2022, AstraZeneca India collaborated with Alveofit, a respiratory healthcare platform powered by SaaS and IoT. This collaboration seeks to provide IoT-enabled handheld spirometers in hospitals across India.

• In June 2021, ERT introduced ERT iSpiro Virtual Visits, which allow for real-time coaching during at-home pulmonary function tests (PFT). ERT fulfills its goal to provide customer and patient-centered innovations that enable decentralization with iSpiro Virtual Visits.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2022 to 2032. Spherical Insights has segmented the global spirometer market based on the below-mentioned segment

Spirometer Market, Product Type Analysis

• Devices
• Software
• Accessories & Consumables

Spirometer Market, Type Analysis

• Volume Measurement
• Peak Flow Meters

Spirometer Market, Application Analysis

• Chronic Obstructive Pulmonary Disorder (COPD)
• Asthma
• Others

Spirometer Market, End-User Analysis

• Hospitals
• Diagnostic Centers
• Homecare Settings
• Physician/Primary Care Offices or Clinics
• Other Facilities

Spirometer Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa